Recurrent Mixed Phenotype Acute Leukemia

specific

The reemergence of mixed phenotype acute leukemia after a period of remission.

32

Centers

38

Active Trials

Cancer Funding

Top Centers for Recurrent Mixed Phenotype Acute Leukemia(32)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
69.8
269.8
3
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
69.8
4
NCI Comprehensive
Active Research Program
69.8
5
Active Research Program
69.8
6
Active Research Program
69.8
7
NCI Comprehensive
Active Research Program
47.3
8
NCI Comprehensive
Active Research Program
47.3
9
NCI Comprehensive
Active Research Program
47.3
10
NCI Comprehensive
Active Research Program
47.3
11
NCI Comprehensive
Active Research Program
47.3
12
NCI Comprehensive
Active Research Program
47.3
13
NCI Comprehensive
Active Research Program
47.3
14
NCI Comprehensive
Active Research Program
47.3
15
NCI Comprehensive
Active Research Program
47.3
16
NCI Comprehensive
Active Research Program
47.3
17
NCI Clinical
Active Research Program
47.3
18
NCI Comprehensive
Active Research Program
47.3
19
NCI Comprehensive
Active Research Program
47.3
20
NCI Clinical
Active Research Program
47.3
21
NCI Comprehensive
Active Research Program
47.3
22
NCI Clinical
Active Research Program
47.3
23
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
47.3
24
NCI Comprehensive
Active Research Program
47.3
25
Active Research Program
47.3
26
Active Research Program
47.3
2747.3
28
Active Research Program
47.3
29
Active Research Program
47.3
30
Active Research Program
47.3
31
Active Research Program
47.3
32
BC CancerVancouver, BC
Active Research Program
47.3

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →